Compounds > fentanyl

fentanyl and citalopram

fentanyl has been researched along with citalopram in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (50.00)	29.6817
2010's	8 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Nagashima, R; Nishikawa, T; Tobita, M	1
Jolivette, LJ; Ward, KW	1
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Bellman, K; Knegtel, RM; Settimo, L	1
Bojarski, AJ; Canale, V; Jastrzębska-Więsek, M; Kos, T; Kurczab, R; Partyka, A; Pękala, E; Popik, P; Satała, G; Siwek, A; Słoczyńska, K; Wesołowska, A; Zajdel, P	1
Ailawadhi, S; Baer, MR; Carlson, LA; Sung, KW	1
Lefebvre-Kuntz, D; Reich, M	1
Barann, M; Bönisch, H; Lyutenska, M; Stamer, UM; Stüber, F; Urban, B	1
Armitage, MC; Page, CB; Woolfield, KI	1

Other Studies

16 other study(ies) available for fentanyl and citalopram

Article	Year
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11 Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated	2005
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7 Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution	2005
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism. Bioorganic & medicinal chemistry letters, 2005, Sep-15, Volume: 15, Issue:18 Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride	2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile. Bioorganic & medicinal chemistry, 2016, Jan-15, Volume: 24, Issue:2 Topics: Alkylation; Animals; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Male; Mice; Motor Activity; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Recognition, Psychology; Structure-Activity Relationship; Sulfonamides; Swimming	2016
Serotonin syndrome caused by interaction between citalopram and fentanyl. Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:2 Topics: Aged; Citalopram; Drug Interactions; Drug Therapy, Combination; Fentanyl; Humans; Myelodysplastic Syndromes; Myeloproliferative Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2007
[Serotoninergic antidepressants and opiate analgesics: a sometimes-painful association. A case report]. L'Encephale, 2010, Volume: 36 Suppl 2 Topics: Adenocarcinoma; Administration, Intranasal; Administration, Oral; Aged; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Bone Neoplasms; Citalopram; Drug Interactions; Drug Therapy, Combination; Fentanyl; Humans; Male; Oxycodone; Pain, Intractable; Prostatic Neoplasms; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2010
Effects of opioids on human serotonin transporters. Naunyn-Schmiedeberg's archives of pharmacology, 2015, Volume: 388, Issue:1 Topics: Alfentanil; Analgesics, Opioid; Blood Platelets; Citalopram; Fentanyl; HEK293 Cells; Humans; Hydromorphone; Ketamine; Meperidine; Morphine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tramadol	2015
Serotonin toxicity caused by the interaction of fentanyl and serotonergic medications. Emergency medicine Australasia : EMA, 2016, Volume: 28, Issue:1 Topics: Amitriptyline; Anesthetics, Intravenous; Antidepressive Agents, Tricyclic; Citalopram; Drug Interactions; Emergency Service, Hospital; Female; Fentanyl; Humans; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Tooth Extraction; Young Adult	2016